Regeneron begins first clinical trials of antibody cocktail for treatment, prevention of COVID-19


Regeneron begins first clinical trials of antibody cocktail for treatment, prevention of COVID-19



The antibody cocktail approach may work better for elderly and immuno-compromised patients

via FOX BUSINESS NEWS https://ift.tt/37jt2TH

Post a Comment

Previous Post Next Post